Providence First Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Sell
1,451
-134
-8% -$47.8K 0.18% 124
2025
Q4
$519K Buy
+1,585
New +$503K 0.18% 108
2020
Q4
Sell
-6,150
Closed -$1.56M 88
2020
Q3
$1.56M Buy
+6,150
New +$1.52M 1.53% 22

Other funds holding AMGN

Providence First Trust's AMGN Position: Q1 2026 in Review

Providence First Trust reduced its Amgen (AMGN) stake by 8.5% in Q1 2026, selling an estimated $47.8K and leaving 1,451 shares worth $511K. The position accounts for 0.18% of the portfolio, ranked #124.

Providence First Trust first reported a position in AMGN in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.56M in Q3 2020. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Providence First Trust held 1,451 shares of Amgen worth $511K as of Q1 2026.
  • Providence First Trust sold 134 Amgen shares in Q1 2026, an estimated $47.8K.
  • Amgen made up 0.18% of Providence First Trust's portfolio in Q1 2026, its #124 holding.
  • Providence First Trust first reported a position in Amgen in Q3 2020 and has held it in 3 quarters since.
  • Providence First Trust's Amgen position peaked at $1.56M in Q3 2020.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Providence First Trust's 13F filing for Q1 2026, filed 5 May 2026.